Related references
Note: Only part of the references are listed.Absence of STAT1 in donor-derived plasmacytoid dendritic cells results in increased STAT3 and attenuates murine GVHD
Christian M. Capitini et al.
BLOOD (2014)
Activity of therapeutic JAK 1/2 blockade in graft-versus-host disease
Silvia Spoerl et al.
BLOOD (2014)
Neutrophils Recruited by IL-22 in Peripheral Tissues Function as TRAIL-Dependent Antiviral Effectors against MCMV
Maria A. Stacey et al.
CELL HOST & MICROBE (2014)
CXCL11-dependent induction of FOXP3-negative regulatory T cells suppresses autoimmune encephalomyelitis (Publication with Expression of Concern. See vol. 128, pg. 1200, 2018) (Publication with Expression of Concern. See vol. 127, pg. 3913, 2017)
Yaniv Zohar et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Interleukin-22 Aggravates Murine Acute Graft-Versus-Host Disease by Expanding Effector T Cell and Reducing Regulatory T Cell
Kai Zhao et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2014)
Conventional CD4+ T cells regulate IL-22-producing intestinal innate lymphoid cells
L. L. Korn et al.
MUCOSAL IMMUNOLOGY (2014)
Neutrophil granulocytes recruited upon translocation of intestinal bacteria enhance graft-versus-host disease via tissue damage
Lukas Schwab et al.
NATURE MEDICINE (2014)
IFNα converts IL-22 into a cytokine efficiently activating STAT1 and its downstream targets
Malte Bachmann et al.
BIOCHEMICAL PHARMACOLOGY (2013)
The identification and characteristics of IL-22-producing T cells in acute graft-versus-host disease following allogeneic bone marrow transplantation
Kai Zhao et al.
IMMUNOBIOLOGY (2013)
IL-22 deficiency in donor T cells attenuates murine acute graft-versus-host disease mortality while sparing the graft-versus-leukemia effect
M. Couturier et al.
LEUKEMIA (2013)
Pro-inflammatory signaling by IL-10 and IL-22: bad habit stirred up by interferons?
Heiko Muehl
FRONTIERS IN IMMUNOLOGY (2013)
Interleukin-22 Protects Intestinal Stem Cells from Immune-Mediated Tissue Damage and Regulates Sensitivity to Graft versus Host Disease
Alan M. Hanash et al.
IMMUNITY (2012)
Plasmacytoid dendritic cells and Th17 immune response contribution in gastrointestinal acute graft-versus-host disease
C. Bossard et al.
LEUKEMIA (2012)
Type I-IFNs control GVHD and GVL responses after transplantation
Renee J. Robb et al.
BLOOD (2011)
Recent advances in IL-22 biology
Lauren A. Zenewicz et al.
INTERNATIONAL IMMUNOLOGY (2011)
Long-Term Survival and Late Deaths After Allogeneic Hematopoietic Cell Transplantation
John R. Wingard et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Memory/effector (CD45RBlo) CD4 T cells are controlled directly by IL-10 and cause IL-22-dependent intestinal pathology
Masahito Kamanaka et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
Border patrol: regulation of immunity, inflammation and tissue homeostasis at barrier surfaces by IL-22
Gregory F. Sonnenberg et al.
NATURE IMMUNOLOGY (2011)
Pathological versus protective functions of IL-22 in airway inflammation are regulated by IL-17A
Gregory F. Sonnenberg et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
IL-22 Induces an Acute-Phase Response
Spencer C. Liang et al.
JOURNAL OF IMMUNOLOGY (2010)
Increased T-bet+ cytotoxic effectors and type I interferon-mediated processes in chronic graft-versus-host disease of the oral mucosa
Matin M. Imanguli et al.
BLOOD (2009)
Interleukin (IL)-23 mediates Toxoplasma gondii-induced immunopathology in the gut via matrixmetalloproteinase-2 and IL-22 but independent of IL-17
Melba Munoz et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
Intestinal mucosal barrier function in health and disease
Jerrold R. Turner
NATURE REVIEWS IMMUNOLOGY (2009)
Innate and Adaptive Interleukin-22 Protects Mice from Inflammatory Bowel Disease
Lauren A. Zenewicz et al.
IMMUNITY (2008)
A New Approach to the Blocking of Alloreactive T Cell-Mediated Graft-versus-Host Disease by In Vivo Administration of Anti-CXCR3 Neutralizing Antibody
Shan He et al.
JOURNAL OF IMMUNOLOGY (2008)
Reduction of graft-versus-host disease by histone deacetylase inhibitor suberonylanilide hydroxamic acid is associated with modulation of inflammatory cytokine milieu and involves inhibition of STAT1
Corinna Leng et al.
EXPERIMENTAL HEMATOLOGY (2006)
Inflammatory cytokines and acute graft-versus-host disease after reduced-intensity conditioning allogeneic stem cell transplantation
M Mohty et al.
BLOOD (2005)
Comparative analysis of IRF and IFN-alpha expression in human plasmacytoid and monocyte-derived dendritic cells
A Izaguirre et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2003)
Activation of signal transducer and activator of transcription (STAT) 1 in human chronic inflammatory bowel disease
S Schreiber et al.
GUT (2002)
Cross talk of the interferon-α/β signalling complex with gp130 for effective interleukin-6 signalling
Y Mitani et al.
GENES TO CELLS (2001)
Cloning and characterization of IL-22 binding protein, a natural antagonist of IL-10-related T cell-derived inducible factor/IL-22
L Dumoutier et al.
JOURNAL OF IMMUNOLOGY (2001)
Cross talk between interferon-γ and -α/β signaling components in caveolar membrane domains
A Takaoka et al.
SCIENCE (2000)
Share Paper
